Maaz Ullah is a 25 year old man with hemophilia B from Upper Dir, Pakistan. Diagnosed with retroperitonial hematoma, Maaz Ullah underwent surgery in Peshawar, and was given donated factor provided by the WFH Humanitarian Aid Program. After being discharged, his wound became infected, and progressed enough that it became serious, necessitating a second operation. During this new procedure, Maaz Ullah was given an additional 35,000 IUs of donated factor. Unfortunately, an additional 5,000 IUs of factor were needed to help him—factor which was not available at the hospital. Fortunately, Masood Fareed, President of the Hemophilia Foundation – Pakistan was told about the case and dispatched the balance of the required factor.
The factor used for all of Maaz Ullah procedures was provided by the WFH Humanitarian Aid Program, and was key to him recovering fully from his procedures. He is now enjoying his life as a shopkeeper with his wife and two children.
About the WFH Humanitarian Aid Program
The expanded WFH Humanitarian Aid Program improves the lack of access to care and treatment by providing much needed support for people with inherited bleeding disorders in developing countries. By providing patients with a more predictable and sustainable flow of humanitarian aid donations, the WFH Humanitarian Aid Program makes it possible for patients to receive consistent and reliable access to treatment and care. None of this would be possible without the generous support of Sanofi Genzyme and Sobi, our Visionary Contributors; Grifols, CSL Behring, GC Pharma, our Corporate partners; and Roche and Bayer, our newest donors. To learn more about the WFH Humanitarian Aid Program, visit www.treatmentforall.org.